Breaking News Instant updates and real-time market news.

BLUE

bluebird bio

$60.35

-4.05 (-6.29%)

, CELG

Celgene

$118.51

-3.62 (-2.96%)

17:29
11/30/16
11/30
17:29
11/30/16
17:29

bluebird bio 'pleased' with early data from Phase 1 study of bb2121

bluebird bio (BLUE) announced that interim data from its ongoing Phase 1 clinical study of bb2121, the company's investigational anti-BCMA CAR T cell product candidate in patients with relapsed/refractory multiple myeloma, will be presented on Thursday, December 1, 2016 at the 28th EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium in Munich, Germany. bluebird bio is developing bb2121 in collaboration with Celgene Corporation (CELG). "We are pleased that these early data from our ongoing Phase 1 study of bb2121 demonstrate objective anti-tumor responses in heavily pre-treated patients with multiple myeloma, with all patients in the 15.0 x 107 and 45.0 x 107 CAR+ T cell dose cohorts achieving responses, including among them, patients with stringent complete responses and elimination of minimal residual disease," said David Davidson, M.D., chief medical officer, bluebird bio. "We are also encouraged by the safety profile to date, particularly the lack of severe cytokine release syndrome or neurotoxicity. In light of these positive data, and thanks to the multiple participating clinical sites and centralized manufacturing infrastructure we and our partner Celgene have built for this program, we anticipate efficiently completing the dose escalation stage of the trial and initiating the expansion cohort."

BLUE

bluebird bio

$60.35

-4.05 (-6.29%)

CELG

Celgene

$118.51

-3.62 (-2.96%)

  • 30

    Nov

  • 30

    Nov

  • 03

    Dec

  • 03

    Dec

  • 04

    Dec

BLUE bluebird bio
$60.35

-4.05 (-6.29%)

11/23/16
JANY
11/23/16
NO CHANGE
JANY
Weakness in bluebird bio unwarranted after Juno trial halt, says Janney Capital
11/23/16
11/23/16
NO CHANGE

Buy
bluebird bio weakness unwarranted after Juno trial halt, says Janney Capital
As previously reported, Janney Capital analyst Debjit Chattopadhyay said the weakness in bluebird bio (BLUE) is unwarranted on the heels of Juno's (JUNO) second clinical hold for JCAR015. Chattopadhyay notes several key differences between JCAR015 and bluebird's bb2121, including their targets, diseases, vectors, preconditioning regimens and others. He remains a buyer of bluebird ahead of a "potentially watershed ASH for its lentiglobin platform" and keeps a Buy rating on the stock.
11/23/16
PIPR
11/23/16
NO CHANGE
PIPR
Piper says CAR-T researchers must heed risks highlighted by Juno news
Piper Jaffray analyst Joshua Schimmer said the CAR-T field has "taken another step back" after Juno Therapeutics (JUNO) put a hold on its JCAR015 trial again due to fatal cerebral edema and cautioned companies exploring these therapies to be mindful of "unnecessarily aggressive development and under-appreciation of the potent and possibly highly toxic nature" of the approach. However, Schimmer expressed his confidence that companies he covers in the CAR-T space - namely bluebird bio (BLUE), Cellectis (CLLS), Celgene (CELG), Bellicum Pharmaceuticals (BLCM), Lion Biotechnologies (LBIO) and NantKwest (NK) - will "respect the power of these platforms and remember patients' lives are more important than stock prices."
11/29/16
PIPR
11/29/16
NO CHANGE
PIPR
Piper sees bluebird regaining 'mojo and momentum'
After hosting management for an investor dinner, Piper Jaffray analyst Joshua Schimmer sees bluebird bio regaining its "mojo and momentum." The analyst expects a "steady stream of positive updates and derisking" starting with BCMA CAR-T data update this week and extending into optimizing LentiGlobin's profile for sickle cell and betathal in 2017. Schimmer has an Overweight rating on bluebird shares with a $95 price target. The biotechnology company closed yesterday down 5% to $60.65.
CELG Celgene
$118.51

-3.62 (-2.96%)

11/09/16
STPT
11/09/16
DOWNGRADE
STPT
Hold
Celgene downgraded to Hold from Buy at Standpoint Research
11/09/16
PIPR
11/09/16
NO CHANGE
PIPR
Piper sees improving environment for Biopharma M&A
The biotech sector is seeing a "massive relief rally" given the "surprise trifecta" of a Republican sweep, the voting down of Prop 61 in California and U.S. dollar weakness, Piper Jaffray analyst Joshua Schimmer tells investors in a research note. The door is now open to discuss potential repatriation of cash outside the U.S., which could be a green light on mergers and acquisitions, the analyst adds. He points out that Amgen (AMGN) and Gilead (GILD) hold the most overseas cash, with Celgene (CELG) and Biogen (BIIB) holding several billion as well. Schimmer believes the broader environment may be improving for M&A. He cautions, though, that the election of Trump does not remove the "major drug pricing overhang question."
11/28/16
OPCO
11/28/16
INITIATION
Target $141
OPCO
Outperform
Celgene initiated with an Outperform at Oppenheimer
Oppenheimer analyst Leah Cann initiated Celgene with an Outperform rating and $141 price target, estimating that revenue will grow at a compound annual growth rate of 19% per year for the next five years and that its GAAP EPS can grow by a 31% CAGR over the same span.

TODAY'S FREE FLY STORIES

DFIN

Donnelley Financial Solutions

$21.66

-0.41 (-1.86%)

06:27
06/23/17
06/23
06:27
06/23/17
06:27
Initiation
Donnelley Financial Solutions initiated  »

Donnelley Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLD

Prologis

$57.64

-0.41 (-0.71%)

06:24
06/23/17
06/23
06:24
06/23/17
06:24
Upgrade
Prologis rating change  »

Prologis upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DRE

Duke Realty

$28.28

-0.22 (-0.77%)

06:24
06/23/17
06/23
06:24
06/23/17
06:24
Downgrade
Duke Realty rating change  »

Duke Realty downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,001.30

-0.93 (-0.09%)

, WFM

Whole Foods

$43.20

-0.06 (-0.14%)

06:23
06/23/17
06/23
06:23
06/23/17
06:23
Periodicals
Some believe Whole Foods would give Amazon 'unfair advantage,' Reuters says »

Antitrust experts believe…

AMZN

Amazon.com

$1,001.30

-0.93 (-0.09%)

WFM

Whole Foods

$43.20

-0.06 (-0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

BBBY

Bed Bath & Beyond

$33.74

0.08 (0.24%)

06:21
06/23/17
06/23
06:21
06/23/17
06:21
Technical Analysis
Technical View: Bed Bath & Beyond tumbles after earnings miss expectations »

The company reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

NAP

Navios Maritime Midstream

$9.88

0.13 (1.33%)

06:19
06/23/17
06/23
06:19
06/23/17
06:19
Downgrade
Navios Maritime Midstream rating change  »

Navios Maritime Midstream…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$957.09

-2.36 (-0.25%)

, GOOGL

Alphabet Class A

$976.62

-1.97 (-0.20%)

06:19
06/23/17
06/23
06:19
06/23/17
06:19
Periodicals
Waymo hires former Tesla engineer to lead hardware team, Bloomberg says »

Alphabet's (GOOG,…

GOOG

Alphabet

$957.09

-2.36 (-0.25%)

GOOGL

Alphabet Class A

$976.62

-1.97 (-0.20%)

TSLA

Tesla

$382.61

6.21 (1.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

  • 19

    Jul

  • 02

    Oct

TSN

Tyson Foods

$61.72

0.34 (0.55%)

06:16
06/23/17
06/23
06:16
06/23/17
06:16
Hot Stocks
Tyson Foods to invest $49M to expand Macon, GA distribution center »

Tyson Foods, Inc. is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAIN

Hain Celestial

$32.66

-0.5 (-1.51%)

06:15
06/23/17
06/23
06:15
06/23/17
06:15
Downgrade
Hain Celestial rating change  »

Hain Celestial downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

BA

Boeing

$199.44

0.27 (0.14%)

, EADSY

Airbus

$20.80

-0.07 (-0.34%)

06:14
06/23/17
06/23
06:14
06/23/17
06:14
Periodicals
Boeing announces layoffs at 787 Dreamliner campus, Post and Courier says »

Boeing (BA) is cutting…

BA

Boeing

$199.44

0.27 (0.14%)

EADSY

Airbus

$20.80

-0.07 (-0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$153.40

-0.51 (-0.33%)

, MSFT

Microsoft

$70.26

-0.01 (-0.01%)

06:12
06/23/17
06/23
06:12
06/23/17
06:12
Periodicals
LinkedIn CEO: Sandberg seems 'quite happy' at Facebook, NY Post reports »

Jeff Weiner, the CEO of…

FB

Facebook

$153.40

-0.51 (-0.33%)

MSFT

Microsoft

$70.26

-0.01 (-0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

  • 19

    Jul

  • 20

    Jul

SKT

Tanger Factory

$25.70

0.48 (1.90%)

06:11
06/23/17
06/23
06:11
06/23/17
06:11
Downgrade
Tanger Factory rating change  »

Tanger Factory downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EADSY

Airbus

$20.80

-0.07 (-0.34%)

06:09
06/23/17
06/23
06:09
06/23/17
06:09
Periodicals
Airbus' sales chief Leahy may retire before Dubai Airshow, Reuters reports »

John Leahy, Airbus'…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,001.30

-0.93 (-0.09%)

, TWTR

Twitter

$18.15

0.37 (2.08%)

06:07
06/23/17
06/23
06:07
06/23/17
06:07
Periodicals
Amazon wants to sell Thurs. Night Football ad deals for $2.8M each, Reuters says »

Amazon (AMZN) wants to…

AMZN

Amazon.com

$1,001.30

-0.93 (-0.09%)

TWTR

Twitter

$18.15

0.37 (2.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

  • 19

    Jul

F

Ford

$11.13

0.09 (0.82%)

06:05
06/23/17
06/23
06:05
06/23/17
06:05
Periodicals
Ford recalling nearly 16,000 cars in South Africa due to fire risk, Reuters says »

Ford is recalling almost…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

ENOC

EnerNOC

$7.65

2.25 (41.67%)

06:05
06/23/17
06/23
06:05
06/23/17
06:05
Downgrade
EnerNOC rating change  »

EnerNOC downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBM

IBM

$154.40

0.61 (0.40%)

06:05
06/23/17
06/23
06:05
06/23/17
06:05
Hot Stocks
IBM achieves climate protection goals four years early »

IBM announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIVHY

Vivendi

$22.76

-0.105 (-0.46%)

06:04
06/23/17
06/23
06:04
06/23/17
06:04
Upgrade
Vivendi rating change  »

Vivendi upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAT

Caterpillar

$103.84

0.37 (0.36%)

06:04
06/23/17
06/23
06:04
06/23/17
06:04
Downgrade
Caterpillar rating change  »

Caterpillar downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$104.22

-0.58 (-0.55%)

, GOOG

Alphabet

$957.09

-2.36 (-0.25%)

05:59
06/23/17
06/23
05:59
06/23/17
05:59
Periodicals
Spotify names Staggs, Warrior to board; Parker leaves board, TechCrunch says »

Spotify has appointed…

DIS

Disney

$104.22

-0.58 (-0.55%)

GOOG

Alphabet

$957.09

-2.36 (-0.25%)

GOOGL

Alphabet Class A

$976.62

-1.97 (-0.20%)

CSCO

Cisco

$31.85

0.01 (0.03%)

P

Pandora

$7.80

0.29 (3.86%)

AMZN

Amazon.com

$1,001.30

-0.93 (-0.09%)

AAPL

Apple

$145.63

-0.24 (-0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 28

    Jun

  • 28

    Jun

  • 28

    Jun

  • 28

    Jun

  • 12

    Jul

  • 19

    Jul

  • 08

    Aug

  • 16

    Aug

SPX

S&P 500

05:55
06/23/17
06/23
05:55
06/23/17
05:55
Technical Analysis
S&P 500: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$86.34

3.78 (4.58%)

05:52
06/23/17
06/23
05:52
06/23/17
05:52
Hot Stocks
Novartis Kisqali receives CHMP opinion as first-line treatment for HR+/HER2- »

Novartis announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 12

    Jul

GDX

Market Vector Gold Miners

$22.36

0.25 (1.13%)

05:51
06/23/17
06/23
05:51
06/23/17
05:51
Technical Analysis
Market Vector Gold Miners: Pivot points, pivot high broken »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLD

SPDR Gold Trust

$118.92

0.4 (0.34%)

05:50
06/23/17
06/23
05:50
06/23/17
05:50
Technical Analysis
SPDR Gold Trust: Pivot points, pivot high broken »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$86.34

3.78 (4.58%)

05:50
06/23/17
06/23
05:50
06/23/17
05:50
Hot Stocks
Novartis: half of eligible patients remain in TFR nearly 2 years after Tasigna »

Novartis announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 12

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.